Detalhe da pesquisa
1.
Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation.
Pediatr Blood Cancer
; 68(8): e29067, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33871892
2.
Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant
; 26(5): 884-892, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31891815
3.
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
Biol Blood Marrow Transplant
; 22(2): 248-257, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26327629
4.
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research.
Biol Blood Marrow Transplant
; 19(7): 1102-8, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23632091
5.
Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research.
Haematologica
; 98(2): 185-92, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22983587
6.
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.
Transplant Cell Ther
; 29(6): 346.e1-346.e10, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924931
7.
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.
Biol Blood Marrow Transplant
; 18(2): 280-8, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21810400
8.
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.
Blood
; 115(9): 1850-7, 2010 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20032503
9.
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.
Blood
; 116(3): 366-74, 2010 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20404137
10.
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes.
Transplant Cell Ther
; 28(7): 409.e1-409.e10, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447374
11.
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.
Biol Blood Marrow Transplant
; 17(12): 1796-803, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699879
12.
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.
Biol Blood Marrow Transplant
; 17(12): 1765-74, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21624486
13.
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
Blood
; 112(2): 426-34, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18398065
14.
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.
Biol Blood Marrow Transplant
; 14(2): 187-96, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18215779
15.
Comparison of twin and autologous transplants for multiple myeloma.
Biol Blood Marrow Transplant
; 14(10): 1118-1124, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18804041
16.
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
Biol Blood Marrow Transplant
; 14(10): 1134-1140, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18804043
17.
Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity.
Blood Adv
; 2(16): 2095-2103, 2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30135184
18.
High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study.
Mayo Clin Proc
; 81(7): 880-8, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16835967
19.
Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis.
J Clin Oncol
; 31(21): 2662-70, 2013 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23797000
20.
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.
Clin Lymphoma Myeloma Leuk
; 10(6): 458-63, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21156462